Paper34603296
Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.
St Leger AJ and 3 others. Front Immunol, 2021. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man. Papers, record 34603296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34603296
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ganglia | Major topic |
| Herpes Simplex | Major topic |
| Herpesvirus 1, Human | Major topic |
| Immunity | Major topic |
| Animals | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Disease Models, Animal | |
| Humans | |
| Mice | |
| Trigeminal Ganglion | |
| Virus Latency |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R00 EY025761 | NEI NIH HHS | United States | R00EY025761 | PubMed | NIH RePORTER |
| R01 EY032482 | NEI NIH HHS | United States | R01EY032482 | PubMed | NIH RePORTER |
| R01 AI151290 | NIAID NIH HHS | United States | R01AI151290 | PubMed | NIH RePORTER |
| R01 EY026891 | NEI NIH HHS | United States | R01EY026891 | PubMed | NIH RePORTER |
| 75N93019C00063 | NIAID NIH HHS | United States | PubMed | PubMed | |
| R01 AI122640 | NIAID NIH HHS | United States | R01AI122640 | PubMed | NIH RePORTER |
| R21 AI156527 | NIAID NIH HHS | United States | R21AI156527 | PubMed | NIH RePORTER |
| P30 EY008098 | NEI NIH HHS | United States | P30EY008098 | PubMed | NIH RePORTER |
| R01 NS064022 | NINDS NIH HHS | United States | R01NS064022 | PubMed | NIH RePORTER |
References197
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,891,812 | Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28891812 | PubMed |
| 2 | 30,670,617 | Role for a Filamentous Nuclear Assembly of IFI16, DNA, and Host Factors in Restriction of Herpesviral Infection. | mBio | 2019 | https://conductscience.org/library/papers/30670617 | PubMed |
| 3 | 31,167,920 | CD28 Costimulation Is Required for Development of Herpetic Stromal Keratitis but Does Not Prevent Establishment of Latency. | J Virol | 2019 | https://conductscience.org/library/papers/31167920 | PubMed |
| 4 | 31,217,250 | Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8+ TRM Cells and Reduces Ocular Herpes Simplex Infection and Disease in HLA Transgenic Rabbits. | J Virol | 2019 | https://conductscience.org/library/papers/31217250 | PubMed |
| 5 | 17,360,672 | Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17360672 | PubMed |
| 6 | 12,753,737 | Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. | Immunity | 2003 | https://conductscience.org/library/papers/12753737 | PubMed |
| 7 | 27,099,310 | SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1. | J Virol | 2016 | https://conductscience.org/library/papers/27099310 | PubMed |
| 8 | 22,761,381 | Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes. | J Virol | 2012 | https://conductscience.org/library/papers/22761381 | PubMed |
| 9 | 33,505,247 | AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy. | Front Mol Neurosci | 2020 | https://conductscience.org/library/papers/33505247 | PubMed |
| 10 | 7,560,014 | Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. | J Neuroimmunol | 1995 | https://conductscience.org/library/papers/7560014 | PubMed |
| 11 | 21,429,183 | Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia. | Herpesviridae | 2011 | https://conductscience.org/library/papers/21429183 | PubMed |
| 12 | 28,077,645 | Herpes Simplex Virus 1 Abrogates the cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41. | J Virol | 2017 | https://conductscience.org/library/papers/28077645 | PubMed |
| 13 | 30,333,177 | Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus Macaques. | J Virol | 2019 | https://conductscience.org/library/papers/30333177 | PubMed |
| 14 | 29,329,934 | Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy. | Microbes Infect | 2018 | https://conductscience.org/library/papers/29329934 | PubMed |
| 15 | 32,295,910 | Deletion of Herpes Simplex Virus 1 MicroRNAs miR-H1 and miR-H6 Impairs Reactivation. | J Virol | 2020 | https://conductscience.org/library/papers/32295910 | PubMed |
| 16 | 19,073,721 | Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. | J Virol | 2009 | https://conductscience.org/library/papers/19073721 | PubMed |
| 17 | 28,363,461 | HSV1 latent transcription and non-coding RNA: A critical retrospective. | J Neuroimmunol | 2017 | https://conductscience.org/library/papers/28363461 | PubMed |
| 18 | 19,153,243 | Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. | J Exp Med | 2009 | https://conductscience.org/library/papers/19153243 | PubMed |
| 19 | 19,635,905 | Neuron-interacting satellite glial cells in human trigeminal ganglia have an APC phenotype. | J Immunol | 2009 | https://conductscience.org/library/papers/19635905 | PubMed |
| 20 | 23,966,859 | Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/23966859 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,219 | Herpesvirus reactivation in COVID-19: clinical evidence, mechanistic insights, and research gaps. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979219 | PubMed |
| 42,752,735 | Can photobiomodulation prevent herpes labialis recurrences? A systematic review. | Einstein (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42752735 | PubMed |
| 42,737,859 | Immune Evasion by Neurotropic Viruses: Molecular Strategies, Cellular Targets, and Consequences for CNS Infection. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737859 | PubMed |
| 42,693,538 | Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation. | Virulence | 2026 | https://conductscience.org/library/papers/42693538 | PubMed |
| 42,539,605 | CD163+ perivascular macrophages in schizophrenia: a research framework for testing macrophage-related mechanisms. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42539605 | PubMed |
| 42,445,487 | Remodeling of gut bacteriome and virome in acute retinal necrosis: expansion of Enterobacteriaceae-related taxa. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42445487 | PubMed |
| 42,347,630 | Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347630 | PubMed |
| 42,041,941 | Triple Latency as a Driver of Chronic Inflammation: An Integrative View of HSV, EBV, and CMV Persistence in Immunocompetent Hosts. | Clin Pract | 2026 | https://conductscience.org/library/papers/42041941 | PubMed |
| 41,674,835 | Immune Niche Formation Reveals Mechanisms of Tumor Dormancy and Targeting Opportunities. | Res Sq | 2026 | https://conductscience.org/library/papers/41674835 | PubMed |
| 41,283,666 | Herpesvirus-host interactions in neurological diseases: the immunogenetic role of HLA-E. | J Virol | 2025 | https://conductscience.org/library/papers/41283666 | PubMed |
| 41,156,633 | HSV-1 as a Potential Driver of Alzheimer's Disease. | Pathogens | 2025 | https://conductscience.org/library/papers/41156633 | PubMed |
| 41,012,114 | The Path Towards Effective Long-Lasting Tissue-Targeted Prime/Pull/Keep Herpes Simplex Therapeutic Vaccines. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012114 | PubMed |
| 40,735,359 | Identifying the Multifactorial Triggers of Monthly Recurrent HSV-1 Reactivation: A Case Report. | Int Med Case Rep J | 2025 | https://conductscience.org/library/papers/40735359 | PubMed |
| 40,313,941 | Reappraisal of IgG subclass deficiencies: a retrospective comparative cohort study. | Front Immunol | 2025 | https://conductscience.org/library/papers/40313941 | PubMed |
| 40,120,981 | Daxx and HIRA go viral - How chromatin remodeling complexes affect DNA virus infection. | Tumour Virus Res | 2025 | https://conductscience.org/library/papers/40120981 | PubMed |
| 40,059,820 | Involvement of virus infections and antiviral agents in schizophrenia. | Psychol Med | 2025 | https://conductscience.org/library/papers/40059820 | PubMed |
| 39,466,139 | The opportunities and challenges of epigenetic approaches to manage herpes simplex infections. | Expert Rev Anti Infect Ther | 2024 | https://conductscience.org/library/papers/39466139 | PubMed |
| 38,886,138 | Safety of non-replicative and oncolytic replication-selective HSV vectors. | Trends Mol Med | 2024 | https://conductscience.org/library/papers/38886138 | PubMed |
| 38,651,900 | A dual fluorescent herpes simplex virus type 1 recombinant reveals divergent outcomes of neuronal infection. | J Virol | 2024 | https://conductscience.org/library/papers/38651900 | PubMed |
| 38,347,772 | Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38347772 | PubMed |
Genes56
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34603296
GET https://conductscience.org/api/papers/v1/34603296/references?page=2